{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:01:17Z","timestamp":1761746477556,"version":"build-2065373602"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Corticosteroid therapy remains controversial in the management of septic shock. The putative benefits of glucocorticoids on immunomodulation and rescue of hypothalamic-pituitary-adrenal (HPA) axis dysregulation has\u00a0made it an attractive target for clinical research. However, conflicting trial results have introduced uncertainty into clinical guidance, while risk of harm continues to be a concern. This review summarizes and interprets the current body of evidence for the role of corticosteroid therapy in septic shock and suggests future directions for continued investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Updated guidelines continue to recommend corticosteroids in septic shock, but more robust data for corticosteroids have emerged in community acquired pneumonia (CAP) and acute respiratory distress syndrome (ARDS), which may account for some of the benefit seen in trials on septic shock. Systematic reviews have suggested potential benefits of combination therapy with fludrocortisone, but further research is needed. Significant variation exists in corticosteroid prescribing practices across providers and ICU settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Many uncertainties remain regarding utility of corticosteroids in septic shock. However, they remain a tool for refractory shock in appropriate patients where benefits outweigh harm. Future research should focus on individualized approaches to corticosteroid therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001297","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T07:00:28Z","timestamp":1751266828000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroids in septic shock: a double-edged sword"],"prefix":"10.1097","volume":"31","author":[{"given":"Jane Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin H.","family":"Kollef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"R1-20251029","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Med"},{"key":"R2-20251029","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"R3-20251029","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"key":"R4-20251029","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic\u2013pituitary\u2013adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-20251029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action","volume":"79","author":"Turnbull","year":"1999","journal-title":"Physiol Rev"},{"key":"R6-20251029","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","article-title":"Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells","volume":"87","author":"Radomski","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-20251029","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1164\/ajrccm.161.6.9812004","article-title":"Effects of nitric oxide in septic shock","volume":"161","author":"Vincent","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20251029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.CCM.0000199070.46812.21","article-title":"Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock\u2217","volume":"34","author":"Barth","year":"2006","journal-title":"Crit Care Med"},{"key":"R9-20251029","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"key":"R10-20251029","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1210\/jc.2005-0354","article-title":"Cortisol response in relation to the severity of stress and illness","volume":"90","author":"Widmer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20251029","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/clinem\/dgac201","article-title":"Critical illness\u2013induced corticosteroid insufficiency: what it is not and what it could be","volume":"107","author":"T\u00e9blick","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20251029","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/08850666231183396","article-title":"Sepsis and adrenal insufficiency","volume":"38","author":"Fowler","year":"2023","journal-title":"J Intensive Care Med"},{"key":"R13-20251029","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00134-017-4914-x","article-title":"Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med"},{"key":"R14-20251029","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"R15-20251029","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00003246-199507000-00021","article-title":"Steroid controversy in sepsis and septic shock: a meta-analysis","volume":"23","author":"Lefering","year":"1995","journal-title":"Crit Care Med"},{"key":"R16-20251029","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Crit Care Med"},{"key":"R17-20251029","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jcrc.2011.12.011","article-title":"US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock","volume":"27","author":"Bruno","year":"2012","journal-title":"J Crit Care"},{"key":"R18-20251029","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R19-20251029","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1213\/01.ANE.0000184042.91452.48","article-title":"A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock","volume":"101","author":"Loisa","year":"2005","journal-title":"Anesth Analg"},{"key":"R20-20251029","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R21-20251029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R22-20251029","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R23-20251029","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"R24-20251029","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/CCM.0000000000003889","article-title":"Why my steroid trials in septic shock were \u201cPositive","volume":"47","author":"Annane","year":"2019","journal-title":"Crit Care Med"},{"key":"R25-20251029","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/ALN.0000000000002955","article-title":"Hydrocortisone compared with placebo in patients with septic shock satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: a: post hoc: analysis of the ADRENAL Trial","volume":"131","author":"Venkatesh","year":"2019","journal-title":"Anesthesiology"},{"key":"R26-20251029","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R27-20251029","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","article-title":"Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial","volume":"12","author":"Heming","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R28-20251029","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R29-20251029","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R30-20251029","first-page":"e1000","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Crit Care Explor"},{"key":"R31-20251029","doi-asserted-by":"crossref","first-page":"EVIDoa2300034","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"key":"R32-20251029","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","article-title":"Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: a systematic review and network meta-analysis of randomized controlled trials","volume":"209","author":"Teja","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-20251029","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Med"},{"key":"R34-20251029","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R35-20251029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"The COIITSS Study Investigators\u2217. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","year":"2010","journal-title":"JAMA"},{"key":"R36-20251029","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R37-20251029","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R38-20251029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bja.2023.10.034","article-title":"Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective","volume":"132","author":"Nethathe","year":"2024","journal-title":"BJA Br J Anaesth"},{"key":"R39-20251029","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s00134-024-07616-z","article-title":"Fludrocortisone dose\u2013response relationship in septic shock: a randomised phase II trial","volume":"50","author":"Walsham","year":"2024","journal-title":"Intensive Care Med"},{"key":"R40-20251029","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/bcp.13065","article-title":"Pharmacokinetics of oral fludrocortisone in septic shock","volume":"82","author":"Polito","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R41-20251029","doi-asserted-by":"crossref","first-page":"EVIDe2300105","DOI":"10.1056\/EVIDe2300105","article-title":"The evolving understanding of glucocorticoid treatment in septic shock","volume":"2","author":"Hibbert","year":"2023","journal-title":"NEJM Evid"},{"key":"R42-20251029","doi-asserted-by":"crossref","first-page":"EVIDra2200118","DOI":"10.1056\/EVIDra2200118","article-title":"Immune modulation in sepsis, ARDS, and Covid-19 \u2014 the road traveled and the road ahead","volume":"1","author":"Leligdowicz","year":"2022","journal-title":"NEJM Evid"},{"key":"R43-20251029","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R44-20251029","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"R45-20251029","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SHK.0000000000001651","article-title":"Evaluation of the initiation timing of hydrocortisone in adult patients with septic shock","volume":"55","author":"Sacha","year":"2021","journal-title":"Shock"},{"key":"R46-20251029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SHK.0000000000001316","article-title":"Comparison between continuous and intermittent administration of hydrocortisone during septic shock: a randomized controlled clinical trial","volume":"52","author":"Tilouche","year":"2019","journal-title":"Shock"},{"key":"R47-20251029","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jointm.2024.05.001","article-title":"Influence of hydrocortisone infusion method on the clinical outcome of patients with septic shock: a systematic review and meta-analysis","volume":"5","author":"Li","year":"2025","journal-title":"J Intensive Med"},{"key":"R48-20251029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcrc.2011.06.011","article-title":"Stress hyperglycemia may not be harmful in critically ill patients with sepsis","volume":"27","author":"Tiruvoipati","year":"2012","journal-title":"J Crit Care"},{"key":"R49-20251029","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/CCM.0000000000001650","article-title":"Admission hyperglycemia in critically ill sepsis patients: association with outcome and host response\u2217","volume":"44","author":"van Vught","year":"2016","journal-title":"Crit Care Med"},{"key":"R50-20251029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","year":"2010","journal-title":"JAMA"},{"key":"R51-20251029","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13054-018-2111-0","article-title":"Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2018","journal-title":"Crit Care"},{"key":"R52-20251029","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcrc.2012.11.013","article-title":"Intensive care unit\u2013acquired hypernatremia is an independent predictor of increased mortality and length of stay","volume":"28","author":"Waite","year":"2013","journal-title":"J Crit Care"},{"key":"R53-20251029","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2478\/jccm-2020-0001","article-title":"Prevalence and prognostic impact of hypernatremia in sepsis and septic shock patients in the intensive care unit: a single centre experience","volume":"6","author":"Shirazy","year":"2020","journal-title":"J Crit Care Med"},{"key":"R54-20251029","first-page":"e1196","article-title":"Variation in corticosteroid prescribing practices for patients with septic shock","volume":"7","author":"Soni","year":"2025","journal-title":"Crit Care Explor"},{"key":"R55-20251029","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial","volume":"199","author":"Antcliffe","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:48:40Z","timestamp":1761734920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001297","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"type":"print","value":"1070-5295"},{"type":"electronic","value":"1531-7072"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}